Baillie Gifford & Co. held its stake in shares of Xylem Inc. (NYSE:XYL) during the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 5,457 shares of the industrial products company’s stock at the end of the 2nd quarter. Baillie Gifford & Co.’s holdings in Xylem were worth $302,000 at the end of the most recent quarter.

A number of other institutional investors have also made changes to their positions in the business. BlackRock Inc. grew its holdings in shares of Xylem by 2,452.8% in the 1st quarter. BlackRock Inc. now owns 12,042,342 shares of the industrial products company’s stock worth $604,765,000 after purchasing an additional 11,570,613 shares during the last quarter. USS Investment Management Ltd bought a new stake in shares of Xylem in the 2nd quarter worth about $91,840,000. MARSHALL WACE ASIA Ltd bought a new stake in shares of Xylem in the 1st quarter worth about $54,623,000. Marshall Wace North America L.P. bought a new stake in shares of Xylem in the 1st quarter worth about $54,623,000. Finally, William Blair Investment Management LLC bought a new stake in shares of Xylem in the 2nd quarter worth about $48,151,000. 86.48% of the stock is currently owned by hedge funds and other institutional investors.

TRADEMARK VIOLATION WARNING: This report was originally posted by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are reading this report on another domain, it was illegally stolen and republished in violation of U.S. and international trademark & copyright legislation. The original version of this report can be accessed at https://www.thecerbatgem.com/2017/09/13/baillie-gifford-co-has-302000-stake-in-xylem-inc-xyl.html.

In other Xylem news, insider Kenneth Napolitano sold 9,052 shares of Xylem stock in a transaction dated Wednesday, August 9th. The stock was sold at an average price of $60.16, for a total value of $544,568.32. Following the transaction, the insider now owns 35,303 shares in the company, valued at $2,123,828.48. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, Director Steven R. Loranger sold 66,132 shares of Xylem stock in a transaction dated Thursday, June 29th. The shares were sold at an average price of $55.01, for a total value of $3,637,921.32. Following the completion of the transaction, the director now owns 65,030 shares in the company, valued at approximately $3,577,300.30. The disclosure for this sale can be found here. Insiders own 0.75% of the company’s stock.

Xylem Inc. (XYL) opened at 62.93 on Wednesday. Xylem Inc. has a 12 month low of $45.60 and a 12 month high of $63.44. The company’s 50-day moving average is $59.90 and its 200 day moving average is $53.82. The firm has a market cap of $11.30 billion, a P/E ratio of 40.63 and a beta of 1.17.

Xylem (NYSE:XYL) last released its earnings results on Tuesday, August 1st. The industrial products company reported $0.59 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $0.57 by $0.02. Xylem had a return on equity of 17.26% and a net margin of 6.58%. The firm had revenue of $1.16 billion for the quarter, compared to analysts’ expectations of $1.17 billion. During the same quarter in the previous year, the business posted $0.48 earnings per share. The business’s revenue for the quarter was up 24.9% on a year-over-year basis. Equities research analysts expect that Xylem Inc. will post $2.37 EPS for the current fiscal year.

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, September 20th. Shareholders of record on Thursday, August 31st will be given a $0.18 dividend. This represents a $0.72 dividend on an annualized basis and a yield of 1.14%. The ex-dividend date is Tuesday, August 29th. Xylem’s dividend payout ratio is presently 46.45%.

Several equities research analysts have recently weighed in on the stock. Cowen and Company reaffirmed an “outperform” rating and issued a $70.00 target price (up previously from $60.00) on shares of Xylem in a report on Wednesday, August 9th. Boenning Scattergood reaffirmed an “outperform” rating on shares of Xylem in a report on Tuesday, September 5th. Oppenheimer Holdings, Inc. reaffirmed a “buy” rating on shares of Xylem in a report on Monday, May 22nd. Royal Bank Of Canada upped their target price on shares of Xylem from $58.00 to $64.00 and gave the stock an “outperform” rating in a report on Wednesday, August 2nd. Finally, Stifel Nicolaus reaffirmed a “hold” rating and issued a $52.00 target price on shares of Xylem in a report on Thursday, July 6th. Five investment analysts have rated the stock with a hold rating and ten have given a buy rating to the stock. The company currently has an average rating of “Buy” and a consensus target price of $59.67.

Xylem Company Profile

Xylem Inc is a water technology company. The Company designs, manufactures and services engineered solutions across a range of critical applications. It is an equipment and service provider for water and wastewater applications with a portfolio of products and services addressing the cycle of water, from collection, distribution and use to the return of water to the environment.

Institutional Ownership by Quarter for Xylem (NYSE:XYL)

Receive News & Stock Ratings for Xylem Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Xylem Inc. and related stocks with our FREE daily email newsletter.